Literature DB >> 11943186

Site-directed mutagenesis of the type II TGF-beta receptor indicates a ligand-binding site distinct from that of the type II activin receptor.

Alain Guimond1, Traian Sulea, Ally Pen, Pohien Ear, Maureen D O'Connor-McCourt.   

Abstract

Site-directed mutagenesis was used to map the ligand-binding surface of the type II transforming growth factor-beta receptor extracellular domain (TbetaRII-ECD). Two putative ligand-binding sites were probed, the first being a predicted hydrophobic patch, the second being the finger 1 surface loop. Nine residues were mutated in the context of full-length TbetaRII and the effect of these mutations on ligand-binding and receptor signaling was analyzed. Complementary information was obtained by examining 'natural' evolutionary TbetaRII mutations. Together, the results indicate that residues within the finger 1 region, but not the hydrophobic patch, of the TbetaRII-ECD are required for productive ligand-binding. We conclude that, surprisingly, the ECDs of TbetaRII and type II activin receptor utilize distinct interacting surfaces for binding their respective ligands.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943186     DOI: 10.1016/s0014-5793(02)02378-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  1 in total

1.  Secreted phosphoprotein 24 kD (Spp24) and Spp14 affect TGF-β induced bone formation differently.

Authors:  Haijun Tian; Xiaoda Bi; Chen-Shuang Li; Ke-Wei Zhao; Elsa J Brochmann; Scott R Montgomery; Bayan Aghdasi; Deyu Chen; Michael D Daubs; Jeffrey C Wang; Samuel S Murray
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.